Radiolab
Radiolab

Staph Retreat

A strange brew that's hard to resist, even for a modern day microbe.In the war on devilish microbes, our weapons are starting to fail us. The antibiotics we once wielded like miraculous flaming swords seem more like lukewarm butter knives. But in this episode, originally released in 2015, we fo

Featured Speakers

WNYC Studios Host

Topics Discussed

Episode Summary

Executive Summary: The episode revisits the rise of antibiotic resistance from penicillin to MRSA, then pivots to an unexpected discovery: a 1,100-year-old Anglo-Saxon eye salve from Bald’s Leech Book that powerfully kills staph and MRSA in lab tests. The story blends history, microbiology, and humility about ancient medicine, while noting the remedy is still only in early safety testing and not yet a drug.

Main Topics: Penicillin’s accidental discovery and the antibiotic era (Priority: 5/5): The episode opens with Alexander Fleming’s mold-contaminated petri dish and the birth of penicillin, framing it as a world-changing miracle drug that transformed infectious disease treatment. The rapid rise of antibiotic resistance (Priority: 5/5): The narrative emphasizes how quickly bacteria adapted, with penicillin-resistant staph appearing almost immediately and a broader pattern of drug-resistance cycles undermining successive antibiotics. The collapse of antibiotic development incentives (Priority: 4/5): The story explains why pharmaceutical companies largely stopped investing in antibiotics: development is expensive and slow, while resistance can emerge soon after launch, reducing profitability. A medieval medical text as a source of modern discovery (Priority: 5/5): Freya Harrison and Christina Lee’s friendship leads them to Bald’s Leech Book, where they identify an old remedy for an eye lump/stye and decide to test it scientifically. Experimental validation of the eye salve (Priority: 5/5): The team recreates the recipe with onion/garlic, ox gall, wine, and copper/brass, then tests it on staph and MRSA in lab models, finding dramatic bacterial killing. Reinterpreting the past with scientific humility (Priority: 4/5): The episode argues that medieval remedies should not be dismissed as superstition; some instructions may encode practical knowledge, timing, or standardized preparation methods. From curiosity to clinical possibility (Priority: 4/5): A later update notes the salve has advanced to Phase 1 safety trials and researchers are identifying the active compounds, though it is not yet ready for clinical use.

Key Arguments: Antibiotic resistance emerged almost as soon as penicillin was introduced, showing that bacterial evolution can outpace medical innovation. The antibiotic pipeline has slowed because the economics of drug development do not favor medicines that may lose effectiveness quickly. Ancient remedies can contain real antimicrobial activity, and historical texts may preserve empirically effective treatments. The Bald’s eye salve is not a miracle cure yet, but its repeated lab success suggests it deserves serious scientific investigation. Understanding old medical language and context is essential; what looks like superstition may encode practical instructions or standardized timing. The discovery suggests a broader strategy: mining historical pharmacopeias could yield new leads for modern antimicrobial development.

Data Points: Year of Fleming’s discovery: 1928 - Alexander Fleming’s mold-contaminated staph plates and the origin story of penicillin Time magazine cover year: 1944 - Fleming appears on the cover during World War II as penicillin is celebrated First reported penicillin-resistant staph strains: 5 strains - A Stanford researcher reports resistance shortly after penicillin’s rise Year methicillin introduced: 1960 - A new antibiotic is developed to counter resistant staph Methicillin effectiveness duration: 11 months - The drug works only briefly before resistance appears Clindamycin resistance lag: 1 year - Introduced 1969, resistance reported in 1970 Linezolid resistance lag: 2 years - Introduced 2000, resistance reported in 2002 Antibiotic development cost/time: 10 years and $1 billion - Explains why antibiotic R&D is economically difficult Estimated annual community MRSA deaths: about 2,000 people - Used to underscore the severity of MRSA in the U.S. Age of Bald’s Leech Book: about 1,100 years old - The medieval manuscript containing the eye salve recipe Storage time for the salve: 9 days and nights - The recipe instructs the mixture to sit before use Bacterial kill rate in lab tests: 99.99999% - Freya and Christina’s recreated salve nearly eradicates staph in mock wound tests MRSA kill rate in collaborator test: 90% - Kendra Rumbaugh’s lab reports strong activity against MRSA Phase 1 safety trial year: 2022 - Update notes the salve has passed initial human safety testing Human trial population: healthy humans - Phase 1 testing was done on healthy volunteers, not infected patients

Pivotal Quotes: "The era of penicillin was over before it began." — Narrator/Robert Krolwich: Describing how quickly penicillin resistance appeared after the drug’s introduction "What the f?" — Kendra Rumbaugh: Her reaction after testing Bald’s brew against MRSA and seeing it devastate the bacteria "The past is a foreign country." — Soron Wheeler / quoted idea in discussion: Used to frame the need to understand medieval medicine on its own terms

Implications:* The episode suggests ancient texts may hold overlooked antimicrobial leads and that reexamining historical medicine with modern methods could help address antibiotic resistance, though rigorous testing and safety validation remain essential.

🔓 Sign Up for Unlimited Episode Search

About Radiolab

Radiolab is on a curiosity bender. We ask deep questions and use investigative journalism to get the answers. A given episode might whirl you through science, legal history, and into the home of someone halfway across the world. The show is known for innovative sound design, smashing information into music. It is hosted by Lulu Miller and Latif Nasser.

View all episodes from Radiolab